SQUAMOUS CARCINOMA POORLY DIFFERENTIATED

Clinical trials for SQUAMOUS CARCINOMA POORLY DIFFERENTIATED explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS CARCINOMA POORLY DIFFERENTIATED trials appear

Sign up with your email to follow new studies for SQUAMOUS CARCINOMA POORLY DIFFERENTIATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Glow-in-the-Dark dye could help surgeons spot hidden cancer cells

Diagnosis Not yet recruiting

This early-stage study tests whether a fluorescent dye attached to the cancer drug nivolumab can safely help surgeons see head and neck tumors during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The goal is to check for si…

Matched conditions: SQUAMOUS CARCINOMA POORLY DIFFERENTIATED

Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis

Last updated May 01, 2026 15:57 UTC

SQUAMOUS CARCINOMA POORLY DIFFERENTIATED

Get alerted when new SQUAMOUS CARCINOMA POORLY DIFFERENTIATED trials appear

Glow-in-the-Dark dye could help surgeons spot hidden cancer cells